Back to News
Market Impact: 0.2
Aquestive Therapeutics, Inc. (Nasdaq: AQST) Investor Alert: Schubert Jonckheer Investigating Possible False Statements Following 37% Stock Drop
Source: PR Newswire
Legal & LitigationHealthcare & Biotech
Schubert Jonckheer & Kolbe LLP said it is investigating potential legal claims on behalf of Aquestive Therapeutics investors over allegedly false or misleading statements concerning the company's Anaphylm drug candidate. The article provides no details on the alleged statements, potential damages, or any filed lawsuit.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.20
Ticker Sentiment
AQST-0.55
More News
- High Court coal decision, Firmus IPO, diesel prices
- Former world No. 1 Jon Rahm's lawyer tells court Spaniard is done with LIV Golf after three seasons
- Why Paramount-Warner merger has sparked fears about press freedom
- Profound Medical stock surges 20% on raised Q3 revenue outlook
- Meta's Muse assistant tops app charts. Now it needs to become a habit
- TP-Link problems in US grow amid FCC router ban and four state lawsuits